Kronos Bio
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch Kronos Bio and buy or sell other stocks, ETFs, and their options commission-free!About KRON
Kronos Bio, Inc. is a clinical development biopharmaceutical company. It engages in the business of developing therapeutics that target dysregulated transcription that causes cancer and other serious diseases.
CEODeborah A. Knobelman, PhD
CEODeborah A. Knobelman, PhD
Employees—
Employees—
HeadquartersSan Mateo, California
HeadquartersSan Mateo, California
Founded2017
Founded2017
Employees—
Employees—
KRON Key Statistics
Market cap53.65M
Market cap53.65M
Price-Earnings ratio-0.82
Price-Earnings ratio-0.82
Dividend yield—
Dividend yield—
Average volume—
Average volume—
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$1.46
52 Week high$1.46
52 Week low$0.65
52 Week low$0.65
Stock Snapshot
Kronos Bio(KRON) stock is priced at $0.88, giving the company a market capitalization of 53.65M. It carries a P/E multiple of -0.82.
On 2026-05-14, Kronos Bio(KRON) shares started trading at —, with intraday highs of — and lows of —.
Trading activity shows a volume of 0.
The stock's 52-week range extends from a low of $0.65 to a high of $1.46.
The stock's 52-week range extends from a low of $0.65 to a high of $1.46.
People also own
Based on the portfolios of people who own KRON. This list is generated using Robinhood data, and it’s not a recommendation.
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.